• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

BTI nets JMHW approval for Magnes system

Article

Magnetic source imaging developer Biomagnetic Technologies received some good news with the announcement that Sumitomo Metal Industries, BTI's Japanese distributor, has received approval from the Japanese Ministry of Health and Welfare of BTI's Magnes

Magnetic source imaging developer Biomagnetic Technologies received some good news with the announcement that Sumitomo Metal Industries, BTI's Japanese distributor, has received approval from the Japanese Ministry of Health and Welfare of BTI's Magnes 2500 WH neuromagnetometer for clinical use in Japan. The approval should provide a boost to BTI, which has endured a rough start this year. In March, its stock was delisted from the NASDAQ stock exchange (SCAN 3/19/97). Earlier, the company posted a $2.1 million loss in the first quarter of 1997.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.